Literature DB >> 10400817

Cytokines and bullous pemphigoid.

L D'Auria1, P Cordiali Fei, F Ameglio.   

Abstract

This report reviews the data presented in the literature concerning the presence and levels of different cytokines in sera, lesional tissue or blister fluids of patients with bullous pemphigoid. The list of cytokines analysed includes 21 molecules: interleukins (IL)-1 => 8, IL-10 => 13, IL-15, granulocyte-monocyte-colony stimulating factor (GM-CSF), interferon-gamma (IFN-gamma), oncostatin-M (OSM), regulated upon activation normal T cell expressed and presumably secreted (RANTES), transforming growth factor-beta 1 (TGF-beta 1), tumor necrosis factor-alpha (TNF-alpha) and vascular endothelial growth factor (VEGF). Basic information regarding the functions of these cytokines and their possible involvement in the pathogenetic steps of the disease, such as autoantigen expression, autoantibody induction, complement activation, local cell recruitment and stimulation, resident cell activation, release of various effector molecules and tissue damage are also reported. A specific function for each cytokine in bullous pemphigoid induction cannot be still defined, however, the literature attributes a major role to IL-1, IL-4, IL-5, IL-6, IL-8 and IFN-gamma. On the basis of significant (direct or inverse) correlations found between disease intensity and the blister fluid/serum levels, the following cytokines IL-7, IL-15, RANTES, VEGF and TNF-alpha, besides those previously mentioned, may also be involved in this disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10400817

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  15 in total

Review 1.  Autoimmune subepidermal bullous skin diseases: the impact of recent findings for the dermatopathologist.

Authors:  Roberto Verdolini; Rino Cerio
Journal:  Virchows Arch       Date:  2003-06-11       Impact factor: 4.064

2.  Production of lysophosphatidic acid in blister fluid: involvement of a lysophospholipase D activity.

Authors:  Juliette Mazereeuw-Hautier; Sandra Gres; Madie Fanguin; Clotilde Cariven; Josette Fauvel; Bertrand Perret; Hugues Chap; Jean-Pierre Salles; Jean-Sébastien Saulnier-Blache
Journal:  J Invest Dermatol       Date:  2005-09       Impact factor: 8.551

3.  Factors associated with the activity and severity of bullous pemphigoid: a review.

Authors:  Yangchun Liu; Yiman Wang; Xinyi Chen; Hongzhong Jin; Li Li
Journal:  Ann Med       Date:  2020-03-22       Impact factor: 4.709

4.  Interleukin-16 expression and release in bullous pemphigoid.

Authors:  A Frezzolini; G Cianchini; M Ruffelli; S Cadoni; P Puddu; O De Pità
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

5.  Bullous pemphigoid associated with dipeptidyl peptidase IV inhibitors. A case report and review of literature.

Authors:  Amy Attaway; Tracey L Mersfelder; Sakshi Vaishnav; Joanne K Baker
Journal:  J Dermatol Case Rep       Date:  2014-03-31

Review 6.  The pathophysiology of bullous pemphigoid.

Authors:  Michael Kasperkiewicz; Detlef Zillikens
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 8.667

7.  Serum levels of seven cytokines in premature ventilated newborns: correlations with old and new forms of bronchopulmonary dysplasia.

Authors:  Giovanni Vento; Ettore Capoluongo; Piero G Matassa; Paola Concolino; Valentina Vendettuoli; Cinzia Vaccarella; Simona Frezza; Cecilia Zuppi; Costantino Romagnoli; Franco Ameglio
Journal:  Intensive Care Med       Date:  2006-03-21       Impact factor: 17.440

8.  Multiplex bead array assay for detection of 25 soluble cytokines in blister fluid of patients with complex regional pain syndrome type 1.

Authors:  Claudia Heijmans-Antonissen; Feikje Wesseldijk; Renate Jm Munnikes; Frank Jpm Huygen; Patrick van der Meijden; Wim C J Hop; Herbert Hooijkaas; Freek J Zijlstra
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

9.  TSST-1+Staphylococcus aureus in Bullous Pemphigoid.

Authors:  Kelly N Messingham; Michael P Cahill; Samuel H Kilgore; Ananya Munjal; Patrick M Schlievert; Janet A Fairley
Journal:  J Invest Dermatol       Date:  2021-10-01       Impact factor: 7.590

Review 10.  Experimental models for the autoimmune and inflammatory blistering disease, Bullous pemphigoid.

Authors:  Lisa Leighty; Ning Li; Luis A Diaz; Zhi Liu
Journal:  Arch Dermatol Res       Date:  2007-09-19       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.